(Q47987134)

7 February 2018

title

Asbestos exposure as a risk factor for retroperitoneal fibrosis (English)

1 reference

7 February 2018

0 references

1 reference

3

1 reference

7 February 2018

author name string

Toomas Uibu

1

1 reference

7 February 2018

Panu Oksa

2

1 reference

7 February 2018

Eero Honkanen

4

1 reference

7 February 2018

Kaj Metsärinne

5

1 reference

7 February 2018

Heikki Saha

6

1 reference

7 February 2018

Jukka Uitti

7

1 reference

7 February 2018

Pekka Roto

8

1 reference

7 February 2018

language of work or name

English

0 references

publication date

1 May 2004

1 reference

7 February 2018

published in

The Lancet

1 reference

7 February 2018

volume

363

1 reference

7 February 2018

issue

9419

1 reference

7 February 2018

page(s)

1422-1426

1 reference

7 February 2018

Bilateral ureteral obstruction due to envelopment and compression by an inflammatory retroperitoneal process

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916100-X

7 January 2021

Fibrotic Disorders Associated with Methysergide Therapy for Headache

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916100-X

7 January 2021

Asbestos exposure: a potential cause of retroperitoneal fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916100-X

7 January 2021

Asbestos and idiopathic retroperitoneal fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916100-X

7 January 2021

Chronic periaortitis and periarteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916100-X

7 January 2021

Evidence of autoimmunity in chronic periaortitis: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916100-X

7 January 2021

Finnish Institute of Occupational Health Asbestos Program 1987-1992

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916100-X

7 January 2021

Assessment of occupational exposure in a population based case-control study: comparing postal questionnaires with personal interviews

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916100-X

7 January 2021

Summarizing indices for comparison of cancer incidence data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916100-X

7 January 2021

Asbestos in extrapulmonary sites: omentum and mesentery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916100-X

7 January 2021

Asbestos content of omentum and mesentery in nonoccupationally exposed individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916100-X

7 January 2021

Mediastinal lymphatic efferents from the diaphragm

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916100-X

7 January 2021

Retention of asbestos fibers in the human body

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916100-X

7 January 2021

The molecular basis of asbestos induced lung injury

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916100-X

7 January 2021

Enhanced retention of asbestos fibers in the airways of human smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916100-X

7 January 2021

[Mesothelioma of pleura and pericardium, with metastases to right lung and retroperitoneal lymph nodes]

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916100-X

7 January 2021

Continuing increase in mesothelioma mortality in Britain.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916100-X

7 January 2021

10.1016/S0140-6736(04)16100-X

Identifiers

DOI

1 reference

7 February 2018

1 reference

7 February 2018